>
Switch to:

BridgeBio Pharma Total Current Assets

: $745.38 Mil (As of Sep. 2020)
View and export this data going back to 2019. Start your Free Trial

Total current assets includes Cash And Cash Equivalents, Accounts Receivable, Total Inventories, and Other Current Assets. BridgeBio Pharma's total current assets for the quarter that ended in Sep. 2020 was $745.38 Mil.


BridgeBio Pharma Total Current Assets Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

BridgeBio Pharma Annual Data
Dec17 Dec18 Dec19
Total Current Assets 97.13 445.22 568.62

BridgeBio Pharma Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Total Current Assets Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 558.16 568.62 924.96 861.94 745.38

BridgeBio Pharma Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

BridgeBio Pharma's Total Current Assets for the fiscal year that ended in Dec. 2019 is calculated as

BridgeBio Pharma's Total Current Assets for the quarter that ended in Sep. 2020 is calculated as

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


BridgeBio Pharma  (NAS:BBIO) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

BridgeBio Pharma's Liquidation Value for the quarter that ended in Sep. 2020 is

Liquidation value
= Cash And Cash Equivalents-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=710.681-571.88+0.75 * 0+0.5 * 0
=138.80

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


BridgeBio Pharma Total Current Assets Related Terms


BridgeBio Pharma Total Current Assets Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)